Mechanisms in pulmonary fibrosis;Mécanismes de la fibrogenèse pulmonaire

Revue du Praticien

Volumn 57, Issue 20, 2007, Pages 2222-2226

  Crestani, Bruno ^b   Marchand Adam, Sylvain ^b   Fabre, Aurélie ^b   Dehoux, Monique ^b   Soler, Paul ^a  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL ACTIVATION; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; FIBROBLAST; FIBROGENESIS; FIBROSING ALVEOLITIS; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MESENCHYME CELL; MESOTHELIUM CELL; PNEUMONIA; REVIEW;

APOPTOSIS; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; INFLAMMATION; PULMONARY FIBROSIS;

EID: 38349077103     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Cool CD, Groshong SD, Rai PR, Henson PM, Stewart JS, Brown KK. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 2006;174:654-8.
2. Pierce EM, Carpenter K, Jakubzick C, et al. Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice. Am J Pathol 2007;170:1152-64.
3. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 2003;60:1342-50.
4. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, et al. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 2006;176:5735-9.
5. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007;353:104-8.
6. Westergren-Thorsson G, Garcia de Alba C, Andersson-Sjoland A, Ramirez R, Pardo A, Selman M. Identification of fibrocytes and stromal derived factor-1 (SDF-1/CXCL12) in lung tissues from patients with idiopathic pulmonary fibrosis (IPF). Am J Respir Crit Care Med 2006;173:A769.
7. Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta-1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005;166:1321-32.
8. Jain R, Shaul PW, Borok Z, Willis BC. Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type a receptor-mediated production of TGF-beta1. Am J Respir Cell Mol Biol 2007;37:38-47.
9. Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. PNAS 2006;103:13180-5.
10. Hagimoto N, Kuwano K, Miyazaki H, et al. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol 1997;17:272-8.
11. Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol 2000;279:L143-L51.
12. Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 1998;275:L1192-L9.
13. Barbas-Filho JV, Ferreira MA, Sesso A, Kairalla RA, Carvalho CR, Capelozzi VL. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol 2001;54:132-8.
14. Marchand-Adam S, Fabre A, Mailleux AA, et al. Defect of prohepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:58-66.
15. Tang YW, Johnson JE, Browning PJ, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol 2003;41:2633-40.
16. Zamo A, Poletti V, Reghellin D, et al. HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:123-8.
17. Mulugeta S, Maguire JA, Newitt JL, Russo SJ, Kotorashvili A, Beers MF. Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase 4 and cytochrome c related mechanisms. Am J Physiol Lung Cell Mol Physiol 2007;25:2007.
18. Armanios MY, Chen JJL, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007;356:1317-26.
19. Hodgson U, Pulkkinen V, Dixon M, et al. ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis. Am J Hum Genet 2006;79:149-54.
20. Ramage L, Jones AC, Whelan CJ. Induction of apoptosis with tobacco smoke and related products in A549 lung epithelial cells in vitro. J Inflamm 2006;3:3.
21. Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136-42.
22. Marchal-Sommé J, Uzunhan Y, Marchand-Adam S, et al. Dendritic cells accumulate in human fibrotic interstitial lung disease. Am J Respir Crit Care Med 2007:(sous presse).
23. Feghali-Bostwick CA, Tsai CG, Valentine VG, et al. Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol 2007;179:2592-9.
24. Swigris J, Brown K. Acute interstitial pneumonia and acute exacerbations of idiopathic pulmonary fibrosis. Semin Respir Crit Care Med 2006;27:659-67.